Search results for "Dali"

showing 10 items of 1372 documents

Minimal manifestation status and prednisone withdrawal in the MGTX trial

2020

ObjectiveTo examine whether sustained minimal manifestation status (MMS) with complete withdrawal of prednisone is better achieved in thymectomized patients with myasthenia gravis (MG).MethodsThis study is a post hoc analysis of data from a randomized trial of thymectomy in MG (Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy [MGTX]). MGTX was a multicenter, randomized, rater-blinded 3-year trial that was followed by a voluntary 2-year extension for patients with acetylcholine receptor (AChR) antibody–positive MG without thymoma. Patients were randomized 1:1 to thymectomy plus prednisone vs prednisone alone. Participants were age 18–65 years at enr…

Malemedicine.medical_treatmentAzathioprinelaw.invention0302 clinical medicineRandomized controlled trialPrednisonelawMedicineSingle-Blind Method030212 general & internal medicineYoung adultMiddle AgedThymectomyCombined Modality TherapySubstance Withdrawal Syndrome3. Good healthSettore MED/26 - NEUROLOGIA6.1 PharmaceuticalsAnesthesiaadolescent; adult; animals; combined modality therapy; female; humans; immunosuppressive agents; male; middle aged; myasthenia gravis; prednisone; rats; single-blind method; substance withdrawal syndrome; thymoma; thymus neoplasms; young adult; thymectomyCognitive SciencesFemaleImmunosuppressive Agentsmedicine.drugAdultThymomaAdolescentThymomaClinical Trials and Supportive ActivitiesClinical SciencesMGTX study groupAutoimmune DiseaseArticleYoung Adult03 medical and health sciencesRare DiseasesClinical ResearchMyasthenia GravisPost-hoc analysisAnimalsHumansNeurology & Neurosurgerybusiness.industryNeurosciencesEvaluation of treatments and therapeutic interventionsThymus Neoplasmsmedicine.diseaseMyasthenia gravisRatsThymectomyPrednisoneNeurology (clinical)business030217 neurology & neurosurgeryNeurology
researchProduct

Early endovascular aneurysm repair after percutaneous coronary interventions

2015

Objective The objective of this study was to report long-term results of early endovascular aortic aneurysm repair after percutaneous coronary intervention (PCI). Methods This was a retrospective analysis of all patients presenting with abdominal aortic aneurysm and coronary artery disease treated during the same hospitalization by endovascular aortic aneurysm repair performed soon after PCI. Primary outcomes were perioperative mortality, perioperative complications, survival after treatment, and freedom from reintervention. Results A total of 20 patients were included, and all completed both procedures. No deaths or abdominal aortic aneurysm ruptures occurred between the PCI and the aortic…

Malemedicine.medical_treatmentCoronary DiseaseComorbidityEndovascular aneurysm repairSettore MED/22 - Chirurgia VascolareCoronary artery diseaseAortic aneurysmPostoperative ComplicationsRisk FactorsRetrospective StudieCause of DeathMyocardial infarctionHospital MortalityAged; Aged 80 and over; Aortic Aneurysm Abdominal; Cause of Death; Combined Modality Therapy; Comorbidity; Coronary Disease; Follow-Up Studies; Hospital Mortality; Humans; Italy; Male; Middle Aged; Postoperative Complications; Reoperation; Retrospective Studies; Risk Factors; Survival Rate; Early Medical Intervention; Percutaneous Coronary Intervention; Cardiology and Cardiovascular Medicine; Surgery; Medicine (all)Aged 80 and overMedicine (all)Middle AgedCombined Modality TherapyAbdominal aortic aneurysm2746 SurgerySurvival RateItalycardiovascular systemCardiologyCardiology and Cardiovascular MedicineHumanReoperationmedicine.medical_specialty10216 Institute of Anesthesiology610 Medicine & health2705 Cardiology and Cardiovascular MedicineFollow-Up StudiePercutaneous Coronary InterventionInternal medicineEarly Medical InterventionmedicineHumanscardiovascular diseasesRetrospective StudiesAgedbusiness.industryRisk FactorPercutaneous coronary interventionPerioperativemedicine.disease10020 Clinic for Cardiac SurgerySurgeryConventional PCISurgeryPostoperative ComplicationbusinessFollow-Up StudiesAortic Aneurysm Abdominal
researchProduct

A comparison of the effects of Methylprednisolone Acetate, Sodium Hyaluronate and Tenoxicam in the treatment of non-reducing disc displacement of the…

2018

Background This clinical study aimed to radiologically and clinically compare the effect of intra-articular injection of methylprednisolone, sodium hyaluronate or tenoxicam following arthrocentesis with that of arthrocentesis alone in patients with non-reducing disc displacement. Material and Methods A total of 44 patients radiographically diagnosed with non-reducing disc displacement of the temporomandibular joint (TMJ) were randomly divided into four treatment groups, as follows: Group 1, arthrocentesis alone; Group 2, arthrocentesis plus methylprednisolone acetate; Group 3, arthrocentesis plus sodium hyaluronate; Group 4, arthrocentesis plus tenoxicam. Maximum mouth opening (MMO), latera…

Malemedicine.medical_treatmentSodium hyaluronateAnti-Inflammatory AgentsInjections Intra-Articular03 medical and health scienceschemistry.chemical_compoundPiroxicam0302 clinical medicineTenoxicamMedicineHumansSingle-Blind MethodProspective StudiesHyaluronic AcidGeneral Dentistrymedicine.diagnostic_testViscosupplementsbusiness.industryResearchAnti-Inflammatory Agents Non-SteroidalArthrocentesisMagnetic resonance imaging030206 dentistryMethylprednisolone acetateTemporomandibular Joint Disorders:CIENCIAS MÉDICAS [UNESCO]Combined Modality TherapyTemporomandibular jointMethylprednisolone Acetatemedicine.anatomical_structureOtorhinolaryngologychemistryEffusionMethylprednisolone030220 oncology & carcinogenesisAnesthesiaUNESCO::CIENCIAS MÉDICASSurgeryFemaleOral Surgerybusinessmedicine.drugArthrocentesisMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Postoperative Patient Education in Physiotherapy after Hip Arthroplasty : Patients' Perspective

2016

The objective of the present study was to explore postoperative patient education in physiotherapy from total hip arthroplasty (THA) patients' perspectives, which has been a little-studied area of research. The usefulness of rehabilitation protocols after THA has been debated over the years, and there are no clear guidelines for physiotherapy after THA METHODS: The data for the present qualitative study were collected from nine patients with THA by using individual interviews at the hospital after surgery. The interviews were audio-recorded and analysed by using a phenomenographic method RESULTS: Four different categories of postoperative patient education in physiotherapy after hip arthrop…

Malemusculoskeletal diseases030506 rehabilitationmedicine.medical_specialtyNursing (miscellaneous)patients' perspectivesphenomenographyArthroplasty Replacement Hipmedicine.medical_treatmentPhysical fitnessPhysical Therapy Sports Therapy and RehabilitationPostoperative management03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationPatient Education as TopicRheumatologymedicineHumansOrthopedics and Sports MedicinePostoperative PeriodPhenomenographyhip arthroplastyPhysical Therapy ModalitiesAgedta3126Rehabilitationbusiness.industryRehabilitationPerspective (graphical)postoperative patient education in physiotherapyta3141Middle AgedHip arthroplastyPhysical therapyFemaleChiropractics0305 other medical sciencebusiness030217 neurology & neurosurgeryQualitative researchTotal hip arthroplastyMusculoskeletal Care
researchProduct

Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry

2014

Background: Some studies have shown that switching patients from one tumor necrosis factor (TNF)-alfa inhibitor to another may be beneficial when they have an inadequate response or an adverse event. Objective: We sought to assess the variables predicting the efficacy of the second TNF-alfa inhibitor in patients discontinuing the first TNF-alfa inhibitor. Methods: Data from all 5423 consecutive patients starting TNF-alfa inhibitor therapy for psoriasis between September 2005 and September 2010 who were included in the Italian Psocare registry were analyzed. Results: In 105 patients who switched to a second TNF-alfa inhibitor who had complete follow-up data, 75% improvement in the Psoriasis …

Maleprimary inefficacy75% improvement in the Psoriasis Area Severity Index score; PASI; PASI 75; Psoriasis Area Severity Index; TNF; biologics; efficacy; primary inefficacy; psoriasis; secondary loss of efficacy; switching; tumor necrosis factor; tumor necrosis factor-alfa inhibitors; Adult; Analysis of Variance; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Cohort Studies; Confidence Intervals; Dose-Response Relationship Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunoglobulin G; Italy; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Psoriasis; Receptors Tumor Necrosis Factor; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha; Young AdultSWITHCESefficacyTNFpsoriasis; psoriasis arthritis; pharmachological treatmentPASI 75Severity of Illness IndexReceptors Tumor Necrosis FactorEtanerceptCohort StudiesMonoclonalReceptorsSettore MED/35 - Malattie Cutanee E VenereeRegistriesHumanizedtumor necrosis factor-alfa inhibitors.switchingHazard ratioAntibodies MonoclonalMiddle AgedTreatment OutcomeItalyPredictive value of tests75% improvement in the Psoriasis Area Severity Index scoreFemaleDrugPsoriasis Area Severity IndexbiologicTNF-alphaAdultmedicine.medical_specialtytumor necrosis factorDermatology75% improvement in the Psoriasis Area Severity Index score; PASI; PASI 75; Psoriasis Area Severity Index; TNF; biologics; efficacy; primary inefficacy; psoriasis; secondary loss of efficacy; switching; tumor necrosis factor; tumor necrosis factor-alfa inhibitorsAntibodies Monoclonal Humanizedsecondary loss of efficacyRisk AssessmentAntibodiestumor necrosis factor-alfa inhibitorsDrug Administration ScheduleDose-Response RelationshipYoung AdultSettore MED/35Predictive Value of TestsInternal medicinePsoriasisSeverity of illnessmedicineConfidence IntervalsHumansPsoriasisbiologicsAdverse effectPsoriasis; TNF-alphaProportional Hazards ModelsRetrospective Studiespsoriasibiologics; efficacy; primary inefficacy; psoriasis; secondary loss of efficacy; switching; tumor necrosis factor-alfa inhibitors; Adalimumab; Adult; Analysis of Variance; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Cohort Studies; Confidence Intervals; Dose-Response Relationship Drug; Drug Administration Schedule; Etanercept; Female; Follow-Up Studies; Humans; Immunoglobulin G; Infliximab; Italy; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Psoriasis; Receptors Tumor Necrosis Factor; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult; 2708Analysis of Variancepharmachological treatmentDose-Response Relationship DrugProportional hazards modelbusiness.industrytumor necrosis factor-alfa inhibitorTumor Necrosis Factor-alphaPASIAdalimumabRetrospective cohort studypsoriasis arthritismedicine.diseaseConfidence intervalInfliximabSurgeryImmunoglobulin GMultivariate AnalysisANTI-TNFAbusiness2708Follow-Up Studies
researchProduct

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept…

2012

Objective: To evaluate the risk of serious infections (SIs) in RA patients receiving anti-TNF therapy on the basis of the data included in the GISEA register. METHODS: The study involved 2769 adult patients with long-standing RA (mean age 53.2±13.4years; mean disease duration 9.0±8.3years) enrolled in the GISEA register, who had been treated for at least 6months with TNF inhibitors or had discontinued therapy due to SI: 837 (30%) treated with infliximab (IFN), 802 (29%) with adalimumab (ADA), and 1130 (41%) with etanercept (ETN). RESULTS: 176 patients had experienced at least one of the 226 Sis during the 9years of treatment with an anti-TNF agent, an overall incidence of 31.8/1000 patient-…

Malerheumatoid arthritisArthritisReceptors Tumor Necrosis FactorEtanerceptEtanerceptArthritis RheumatoidAdalimumab; Adult; Aged; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Antirheumatic Agents; Arthritis Rheumatoid; Etanercept; Female; Humans; Immunoglobulin G; Incidence; Infection; Infliximab; Male; Middle Aged; Receptors Tumor Necrosis Factor; Registries; Tumor Necrosis FactorsRheumatoidadalimumabMonoclonalReceptorsImmunology and AllergyRegistriesinfectionsHumanizedAnti-TNF agents; GISEA register; Infections; Predictive factorsIncidence (epidemiology)IncidenceAntibodies MonoclonalAnti-TNF agentsMiddle AgedRheumatoid arthritisAntirheumatic AgentsCohortTumor Necrosis FactorsFemaleInfectionPredictive factorsmedicine.druganti-TNF; serious infections; rheumatoid arthritisAdultmedicine.medical_specialtyanti-TNF therapy; infections; rheumatoid arthritis; adalimumab; etanercept; infliximabanti-TNF therapyserious infectionsImmunologyInfections rheumatoid arthritis anti-TNF therapyAntibodies Monoclonal HumanizedInfectionsAntibodiesInternal medicinemedicineAdalimumabHumansAgedGISEA registerbusiness.industryArthritisAdalimumabanti-TNFGISEA register; Infections; Anti-TNF agents; Predictive factors; Adalimumab; Adult; Aged; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Antirheumatic Agents; Arthritis Rheumatoid; Etanercept; Female; Humans; Immunoglobulin G; Incidence; Infection; Infliximab; Male; Middle Aged; Receptors Tumor Necrosis Factor; Registries; Tumor Necrosis Factorsmedicine.diseaseInfliximabInfliximabConcomitantImmunoglobulin GImmunologyTumor Necrosis Factor InhibitorsbusinessTumor Necrosis Factorinfliximabetanercept
researchProduct

Effects of 12-month home-based physiotherapy on duration of living at home and functional capacity among older persons with signs of frailty or with …

2018

Health concerns, such as frailty and osteoporotic fractures decrease functional capacity and increase use of health and social care services in the aging population. The ability to continue living at home is dependent on functional capacity, which can be enhanced by rehabilitation. We study the effects of a 12-month home-based physiotherapy program with 12-month follow-up on duration of living at home, functional capacity, and the use of social and health care services among older persons with signs of frailty, or with a recently operated hip fracture. This is a non-blinded, parallel group, randomized controlled trial performed in South Karelia Social and Health Care District, Finland (popu…

MaleterveyspalvelutTime Factorssosiaalipalvelutmedicine.medical_treatmentvanhuksetyhteisöllinen asuminenlcsh:GeriatricsCommunity-dwellinglaw.inventionStudy Protocolmurtumat0302 clinical medicineRandomized controlled trialQUALITY-OF-LIFElawSurveys and QuestionnairesHealth careMedicine030212 general & internal medicineluunmurtumatFinlandAged 80 and overeducation.field_of_studyHip fractureRehabilitationkotisairaanhoitokotikuntoutusHome Care ServicesFunctional Independence Measurecommunity-dwellingFES-IEXERCISE PROGRAM3. Good healthTreatment OutcomeSocial and health care serviceship fracturesFemaleHEALTHIndependent LivingikääntyneetREHABILITATIONPopulation ageingmedicine.medical_specialtyFrail ElderlykotihoitoPopulation03 medical and health sciencesQuality of life (healthcare)toimintakykyFunctional capacityHumanshome-based physiotherapyeducationMETAANALYSISPhysical Therapy ModalitiesAgedduration of living at homeHip Fracturesbusiness.industryDISABILITYPHYSICAL PERFORMANCE BATTERYADULTSDuration of living at homeHome-based physiotherapymedicine.diseasefrail elderlylonkkaLOWER-EXTREMITY FUNCTIONlcsh:RC952-954.6Nutrition Assessment3121 General medicine internal medicine and other clinical medicineQuality of LifePhysical therapyAccidental FallsGeriatrics and Gerontologybusinesssocial and health care services030217 neurology & neurosurgeryBMC Geriatrics
researchProduct

An average structure model of the intermediate phase between sodalite and cancrinite

2018

Abstract Powder samples of the intermediate phase between sodalite and cancrinite (INT) have been synthesized hydrothermally. The formation of the INT phase was proved by both PXRD and TGA analysis and its stoichiometric composition was found to be |Na6.95(1)(CO3)0.48(2) (H2O)6.18(6)|[AlSiO4]6. The comparison of the intensity ratios of PXRD data with a SCXRD measurement indicates the formation of a comparable phase with the typical strong stacking disorder. The hexagonal lattice parameters with a=1266.3(2) pm and c=1586(1) pm and the unit cell setting were determined by Pawley fits. The average lattice and the stacking disorder along c axis could be confirmed by the reconstruction of three-…

Materials science02 engineering and technology010502 geochemistry & geophysics021001 nanoscience & nanotechnologyCondensed Matter Physics01 natural sciencesCancriniteInorganic ChemistryCrystallographychemistry.chemical_compoundchemistryPhase (matter)SodaliteGeneral Materials ScienceStructured model0210 nano-technology0105 earth and related environmental sciencesZeitschrift für Kristallographie - Crystalline Materials
researchProduct

Hackmanite—The Natural Glow-in-the-Dark Material

2020

“Glow-in-the-dark” materials are known to practically everyone who has ever traveled by airplane or cruise ship, since they are commonly used for self-lit emergency exit signs. The green afterglow, persistent luminescence (PeL), is obtained from divalent europium doped to a synthetic strontium aluminate, but there are also some natural minerals capable of afterglow. One such mineral is hackmanite, the afterglow of which has never been thoroughly investigated, even if its synthetic versions can compete with some of the best commercially available synthetic PeL materials. Here we combine experimental and computational data to show that the white PeL of natural hackmanite is generated and cont…

Materials scienceGeneral Chemical Engineeringchemistry.chemical_element02 engineering and technologyNatural mineral010402 general chemistry01 natural sciencesNatural (archaeology)Synthetic materialsSODALITEchemistry.chemical_compoundPersistent luminescenceMaterials ChemistryTUGTUPITESPECTRACOLORluminesenssiIRONStrontium aluminate[CHIM.MATE]Chemical Sciences/Material chemistryOPTICAL-PROPERTIESGeneral ChemistryRESONANCE021001 nanoscience & nanotechnology0104 chemical sciencesAfterglow[CHIM.THEO]Chemical Sciences/Theoretical and/or physical chemistryCENTERSPhysics and AstronomychemistryChemical physicsLUMINESCENCE0210 nano-technologyEuropiumLuminescenceChemistry of Materials
researchProduct

Template-free synthesis and structural evolution of discrete hydroxycancrinite zeolite nanorods from high-concentration hydrogels.

2017

We report the synthesis and characterization of hydroxycancrinite zeolite nanorods by a simple hydrothermal treatment of aluminosilicate hydrogels at high concentrations of precursors without the use of structure-directing agents. Transmission electron microscopy (TEM) analysis reveals that cancrinite nanorods, with lengths of 200-800 nm and diameters of 30-50 nm, exhibit a hexagonal morphology and are elongated along the crystallographic c direction. The powder X-ray diffraction (PXRD), Fourier transform infrared (FT-IR) and TEM studies revealed sequential events of hydrogel formation, the formation of aggregated sodalite nuclei, the conversion of sodalite to cancrinite and finally the gro…

Materials scienceNanotechnology02 engineering and technology010402 general chemistry021001 nanoscience & nanotechnology01 natural sciences0104 chemical sciencesCancrinitechemistry.chemical_compoundchemistryChemical engineeringNanocrystalSelf-healing hydrogelsSodaliteZeta potentialGeneral Materials ScienceNanorod0210 nano-technologyZeolitePowder diffractionNanoscale
researchProduct